Effects of the 5-HT2A and DRD3 genotypes on cortical morphology and functional connectivity density in drug-naïve first episode schizophrenia

Schizophr Res. 2020 Feb:216:213-221. doi: 10.1016/j.schres.2019.11.058. Epub 2019 Dec 6.

Abstract

The 5-hydroxytryptamine 2A receptor (5-HT2A) and dopamine D3 receptor (DRD3) have been extensively studied as promising candidate genes for schizophrenia. Magnetic resonance imaging studies have demonstrated that schizophrenia is associated with widespread structural and functional abnormalities in the brain. Serotonin and dopamine receptors play crucial roles in the development of the human cerebral cortex and brain activity. However, how the 5-HT2A and DRD3 genes impact brain structure and function in schizophrenia remains unknown. In the present study, we investigated the main effect of disease state and the interaction effect between disease state and genotype of these two genes on cortical volume, thickness, surface area and functional connectivity density (FCD) in fifty-five drug-naïve first episode schizophrenia patients and fifty-three healthy controls. We found that the differences in local FCD (lFCD) and global FCD (gFCD) between patients and healthy controls were predominantly located in brain hub regions. The significant interaction effects of disease state and 5-HT2A and DRD3 genes on brain structure and function were mainly located in the temporal cortex. Our findings may help to improve the understanding of the relationship between 5-HT2A and DRD3 genotypes and schizophrenia pathogenesis.

Keywords: 5-Hydroxytryptamine 2A receptor; Cortical morphology; Dopamine D3 receptor; First episode schizophrenia; Functional connectivity density.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cerebral Cortex / diagnostic imaging
  • Genotype
  • Humans
  • Pharmaceutical Preparations*
  • Receptors, Dopamine D3 / genetics
  • Schizophrenia* / diagnostic imaging
  • Schizophrenia* / genetics

Substances

  • DRD3 protein, human
  • Pharmaceutical Preparations
  • Receptors, Dopamine D3